Testing Miglustat Administration in Subjects With Spastic Paraplegia 11

NCT04768166 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Spastic Paraparesis

Interventions

DRUG: Miglustat 100 MG

Sponsor

IRCCS Fondazione Stella Maris